ABOUT LDN-27219 DRUG DEVELOPMENT PIPELINE

In contrast to neurodegerative diseases and cancer, the contribution of TG2 activity to celiac sprue pathogenesis is reasonably properly recognized. The deamidation of unique glutamine residues specific by TG2 in gluten peptides has long been proven to boost peptide binding for the condition-connected proteins HLA-DQ2/8, that are the one regarded g